Home / Latest Market Insights / Cancidas Market- Global Growth, Trends And Forecast (2022 - 2029) By Indication (Candidiasis, Thrush) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Regions
Cancidas Market- Global Growth, Trends and Forecast (2022 - 2029) By Indication (Candidiasis, Thrush) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Regions
Over the forecast period the Cancidas Market will register a CAGR 0.19 % in terms of revenue and the global Market size will reach USD in 498 Million by 2029.
Cancidas Market Overview
Cancidas is a lipopeptide antifungal medication developed by James Balkovec, Regina Black, and Frances A. Bouffard for Merck & Co., Inc. It belongs to the echinocandins, a novel class of antifungals. It acts by blocking the enzyme glucan synthase, which disrupts the fungal cell wall's integrity. The United States Food and Drug Administration authorized Cancidas as the first inhibitor of fungal glucan production.
Cancidas is injected into the vein. It has been shown to be useful in the treatment of Aspergillus and Candida species fungal infections. It belongs to the echinocandin family of antifungal medicines, which is a novel class of antifungal drugs having wide antifungal activity against all Candida species. In well-defined clinical contexts such as invasive Candida infections, Candida oesophagitis, and candidaemia, all three medicines in this class have been shown to be extremely effective or superior to therapy with fluconazole or Amphotericin B. Cancidas has been classified as class C since it has been proven in animal research to have embroyotoxic effects. Only if the benefit to the mother clearly outweighs the danger to the foetus should it be provided to pregnant women.
What is our Cancidas Market report scope?
Forecast Period 2022 to 2029
CAGR of 0.19 % during the review period (2022 to 2029).
By Distribution Channel
Fresenius SE & Co. KGaA (Fresenius Kabi)
Juno Pharmaceuticals (MDA Inc.)
Merck & Co., Inc.
Rest of the World
Rest of Europe
Rest of Asia-Pacific
Middle East & Africa
2017 to 2021
2022 to 2029
Number of Pages
Who are the Major Players in Cancidas Market?
Market Growth Reports lists out all the Cancidas Market companies that are presently striving to reduce the impact of Covid-19 pandemic on the Market- Athenex, Inc., Cipla Inc., Fresenius SE & Co. KGaA (Fresenius Kabi), Juno Pharmaceuticals (MDA Inc.), Merck & Co., Inc., Others
Athenex Announces Recent Product Launches in 503B and Specialty Injectables Business Units
BUFFALO, N.Y., Feb. 13, 2018 - Athenex, Inc. a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced recent product launches from Athenex Pharmaceutical Division (“APD”). These launches highlight the continued portfolio growth with an emphasis on oncology or oncology supportive therapy, a business strategy of Athenex’s commercial business as an effective supplement to its progressing clinical pipeline focused on oncology.
What are the major Indication, Distribution Channel for Cancidas Market?
By Indication, it is segmented into
By Distribution Channel it is segmented into
Cancidas Market Regional Analysis
Throughout the projected period, North America is likely to lead the global Cancidas market. This dominance is mostly due to growing rates of vaginal, vulvovaginal, and fungemia candidiasis as a result of changing lifestyles and increased stress levels. Increased cases of candidemia and invasive aspergillosis in the United States due to a large geriatric population.
In addition, the market is fueled by an increase in antibiotic prescriptions and uncontrolled diabetes in the region. Over the projected period, the presence of important players and early product releases in the area are likely to contribute significantly to the growth of worldwide market revenue.
SECONDARY RESEARCH Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.